Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

Exact Sciences Corp (EXAS) stock saw a modest uptick, ending the day at $69.21 which represents a slight increase of $1.22 or 1.79% from the prior close of $67.99. The stock opened at $68.14 and ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Hopping backward is a good test to see if someone's ACL surgery has gone well, a new study says. That backward hop is an ...

The Harvard School of Public Health faculty approved a resolution to establish a University senate planning body on Tuesday, ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

The aorta, one of the "great arteries," carries blood away from the heart to support circulation throughout the body. However ...

Imagine driving a vehicle on a day when there is a lot of traffic. In a complex task like this one, we need to scan the ...

This influx of spending provided Amsterdam with a significant boost, with economist Walther Ploos van Amstel of the Amsterdam ...

SPOILER ALERT! This post contains details from the premiere episode of Marvel’s Agatha All Along. Agatha All Along has ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Astronomers study stars by looking at the different colors of light they emit—colors they capture and analyze using ...